Company Website

Contact
Kathleen Marzec
Kathleen.Marzec@pfizer.com
904-652-7920

Virtual Exhibit Hall Home

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.
 

Additional Information
Braftovi-Mektovi